RAC 0.28% $1.78 race oncology ltd

Ann: Breakthrough Zantrene Heart Protection Discovery, page-145

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,839 Posts.
    lightbulb Created with Sketch. 653
    wow! It does make you think!

    the beautiful thing about RAC's latest discovery that Zantrene is cardio-protective in presence of Doxorubicin is that it is so easy for everyone to understand. This hasn’t been the case for the finding that Zantrene inhibits over-expression of FTO in cancer.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.